The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
Open accessAbstract
PurposeThe 2015 American College of Medical Genetics and Genomics-Association for Molecular Pathology (ACMG-AMP) guidelines were a major step toward establishing a common framework for variant classification. In practice, however, several aspects of the guidelines lack specificity, are subject to varied interpretations, or fail to capture relevant aspects of clinical molecular genetics. A simple implementation of the guidelines in their current form is insufficient for consistent and comprehensive variant classification.MethodsWe undertook an iterative process of refining the ACMG-AMP guidelines. We used the guidelines to classify more than 40,000 clinically observed variants, assessed the outcome, and refined the classification criteria to capture exceptions and edge cases. During this process, the criteria evolved through eight major and minor revisions.ResultsOur implementation: (i) separated ambiguous ACMG-AMP criteria into a set of discrete but related rules with refined weights; (ii) grouped certain criteria to protect against the overcounting of conceptually related evidence; and (iii) replaced the "clinical criteria" style of the guidelines with additive, semiquantitative criteria.ConclusionSherloc builds on the strong framework of 33 rules established by the ACMG-AMP guidelines and introduces 108 detailed refinements, which support a more consistent and transparent approach to variant classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
ClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Amendola, L. M., Jarvik, G. P., Leo, M. C., McLaughlin, H. M., Akkari, Y., Amaral, M. D., Berg, J. S., Biswas, S., Bowling, K. M., Conlin, L. K., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.024 · Cited by 551
Grimm, D. G., Azencott, C., Aicheler, F., Gieraths, U., MacArthur, D. G., Samocha, K. E., Cooper, D. N., Stenson, P. D., Daly, M. J., Smoller, J. W., et al. (2015) · Human Mutation · doi:10.1002/humu.22768 · Cited by 356
Hereditary breast cancer: new genetic developments, new therapeutic avenues
Campeau, P. M., Foulkes, W. D., & Tischkowitz, M. D. (2008) · Human Genetics · doi:10.1007/s00439-008-0529-1 · Cited by 320
Mohapatra, B., Jimenez, S., Lin, J. H., Bowles, K. R., Coveler, K. J., Marx, J. G., Chrisco, M. A., Murphy, R. T., Lurie, P. R., Schwartz, R. J., et al. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00142-2 · Cited by 269
CDKN2A Mutations in Multiple Primary Melanomas
Monzon, J., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J., Hogg, D., & Lassam, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381305 · Cited by 264
Caveolin-3 in muscular dystrophy
McNally, E. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.871 · Cited by 232
Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S. E., & Topper, S. E. (2017) · Genome Medicine · doi:10.1186/s13073-017-0403-7 · Cited by 232
Self-citationAndreasen, C., Nielsen, J. B., Refsgaard, L., Holst, A. G., Christensen, A. H., Andreasen, L., Sajadieh, A., Haunsø, S., Svendsen, J. H., & Olesen, M. S. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.283 · Cited by 214
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system
Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J., & Marra, G. (2002) · Gastroenterology · doi:10.1053/gast.2002.30296 · Cited by 212
Bos, J. M., Will, M. L., Gersh, B. J., Kruisselbrink, T. M., Ommen, S. R., & Ackerman, M. J. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.025 · Cited by 197
A systematic approach to assessing the clinical significance of genetic variants
Duzkale, H., Shen, J., McLaughlin, H., Alfares, A., Kelly, M., Pugh, T., Funke, B., Rehm, H., & Lebo, M. (2013) · Clinical Genetics · doi:10.1111/cge.12257 · Cited by 183
Tournier, I., Vezain, M., Martins, A., Charbonnier, F., Baert-Desurmont, S., Olschwang, S., Wang, Q., Buisine, M. P., Soret, J., Tazi, J., et al. (2008) · Human Mutation · doi:10.1002/humu.20796 · Cited by 163
Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae
Shimodaira, H., Filosi, N., Shibata, H., Suzuki, T., Radice, P., Kanamaru, R., Friend, S. H., Kolodner, R. D., & Ishioka, C. (1998) · Nature Genetics · doi:10.1038/1277 · Cited by 153
Germline Mutations of the CDKN2 Gene in UK Melanoma Families
Harland, M., Meloni, R., Gruis, N. A., Pinney, E., Brookes, S., Spurr, N. K., Frischauf, A., Bataille, V. A., Peters, G., Cuzick, J. M., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2061 · Cited by 143
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
Walker, G. J., Hussussian, C. J., Flores, J. F., Glendening, M. J., Haluska, F. G., Dracopoli, N. C., Hayward, N. K., & Fountain, J. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1845 · Cited by 141
Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy
Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J. M., Atherton, J. J., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.44 · Cited by 137
Tools for Predicting the Functional Impact of Nonsynonymous Genetic Variation
Tang, H., & Thomas, P. D. (2016) · Genetics · doi:10.1534/genetics.116.190033 · Cited by 117
Temperature-Sensitive Mutants of p16CDKN2 Associated with Familial Melanoma
Parry, D., & Peters, G. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3844 · Cited by 104
Wang, Q., Chen, S., Chen, Q., Wan, X., Shen, J., Hoeltge, G. A., Timur, A. A., Keating, M. T., & Kirsch, G. E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013300 · Cited by 90
Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
Flores, J. F., Pollock, P. M., Walker, G. J., Glendening, J. M., Lin, A. H.-T., Palmer, J. M., Walters, M. K., Hayward, N. K., & Fountain, J. W. (1997) · Oncogene · doi:10.1038/sj.onc.1201470 · Cited by 84
E-cadherin mutations and cell motility: A genotype–phenotype correlation
Mateus, A. R., Simões‐Correia, J., Figueiredo, J., Heindl, S., Alves, C. C., Suriano, G., Luber, B., & Seruca, R. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.020 · Cited by 77
Population-Based Prevalence of CDKN2A Mutations in Utah Melanoma Families
Eliason, M. J., Larson, A. A., Florell, S. R., Zone, J. J., Cannon‐Albright, L., Samlowski, W. E., & Leachman, S. A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700094 · Cited by 60
Wen, J., & Brogna, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360514 · Cited by 54
Corso, G., Roviello, F., Paredes, J., Pedrazzani, C., Novais, M., Simões‐Correia, J., Marrelli, D., Cirnes, L., Seruca, R., Oliveíra, C., et al. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.03.001 · Cited by 49
Roviello, F., Corso, G., Pedrazzani, C., Marrelli, D., Falco, G. D., Berardi, A., Garosi, L., Suriano, G., Vindigni, C., Stefano, A. D., et al. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.10.028 · Cited by 46
Wanat, J. J., Singh, N., & Alani, E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl479 · Cited by 39
Hinrichsen, I., Brieger, A., Trojan, J., Zeuzem, S., Nilbert, M. C., & Plotz, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3299 · Cited by 39
Genuardi, M., Carrara, S. C., Anti, M., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200363 · Cited by 38
Jovanovic, B., Egyházi, S., Eskandarpour, M., Ghiorzo, P., Palmer, J. M., Bianchi‐Scarrà, G., Hayward, N. K., & Hansson, J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.287 · Cited by 37
BBS8 is rarely mutated in a cohort of 128 Bardet–Biedl syndrome families
Stoetzel, C., Laurier, V., Faivre, L. O., Mégarbané, A., Perrin‐Schmitt, F., Verloès, A., Bonneau, D., Mandel, J., Cossée, M., & Dollfus, H. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0320-2 · Cited by 36
Alagille Syndrome in Adult Patients: It Is Never Too Late
Jacquet, A., Guiochon‐Mantel, A., Noël, L., Houssaïni, T. S., Bédossa, P., Hadchouel, M., Grünfeld, J., & Fakhouri, F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.02.262 · Cited by 35
Alagille syndrome and a JAG1 mutation: 41 cases of experience at a single center
Ahn, K. J., Yoon, J. K., Kim, G. B., Kwon, B. S., Go, J. M., Moon, J. S., Bae, E. J., & Noh, C. I. (2015) · Korean Journal of Pediatrics · doi:10.3345/kjp.2015.58.10.392 · Cited by 27
A Clinical Approach to Inherited Hypertrophy
Dunn, K. E., Caleshu, C. A., Cirino, A. L., Ho, C. Y., & Ashley, E. A. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959387 · Cited by 27
From evidence-based medicine to genomic medicine
Kumar, D. (2007) · Genomic Medicine · doi:10.1007/s11568-007-9013-6 · Cited by 25
Garcia, J., Tahiliani, J., Johnson, N. M., Aguilar, S. J., de Bernabé, D. B.-V., Daly, A., Decker, E., Haverfield, E. V., Herrera, B., Murillo, L., et al. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00020 · Cited by 25
Self-citationMolecular Characterization of Melanoma Cases in Denmark Suspected of Genetic Predisposition
Wadt, K., Aoude, L. G., Krogh, L., Sunde, L., Bojesen, A., Grønskov, K., Nine, W., Ek, J., Morten, T.-A., Andersen, M. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122662 · Cited by 23
Nicholls, M. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu375 · Cited by 16
Cited by
Disease variant prediction with deep generative models of evolutionary data
Frazer, J., Notin, P., Dias, M., Gomez, A., Min, J. K., Brock, K., Gal, Y., & Marks, D. S. (2021) · Nature · doi:10.1038/s41586-021-04043-8 · Cited by 791
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Nicolosi, P., Ledet, E., Yang, S., Michalski, S., Freschi, B., O’Leary, E., Esplin, E. D., Nussbaum, R. L., & Sartor, O. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6760 · Cited by 365
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Beitsch, P. D., Whitworth, P. W., Hughes, K., Patel, R., Rosen, B., Compagnoni, G., Baron, P., Simmons, R., Smith, L. A., Grady, I., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01631 · Cited by 363
Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines
Tavtigian, S. V., Harrison, S. M., Boucher, K. M., & Biesecker, L. G. (2020) · Human Mutation · doi:10.1002/humu.24088 · Cited by 358
Metadata
- Authors
- Nykamp, K., Anderson, M., Powers, M., Garcia, J., Herrera, B., Ho, Y.-Y., Kobayashi, Y., Patil, N., Thusberg, J., Westbrook, M., The Invitae Clinical Genomics Group, & Topper, S.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 19
- Issue
- 10
- Pages
- 1105-1117
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2612091911
- Cited by
- 762
- References
- 40
- FWCI
- 31.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.